Chromium VI-induced apoptosis in a human bronchial epithelial cell line (BEAS-2B) and a lymphoblastic leukemia cell line (MOLT-4)

Journal of Occupational and Environmental Medicine

Volumn 48, Issue 3, 2006, Pages 319-325

  Gambelunghe, Angela ^a   Piccinini, Renza ^a   Abbritti, Giuseppe ^a   Ambrogi, Maura ^a   Ugolini, Barbara ^a   Marchetti, Cristina ^a   Migliorati, Graziella ^a   Balducci, Chiara ^a   Muzi, Giacomo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CASPASE 3 INHIBITOR; CASPASE 8 INHIBITOR; CASPASE 9 INHIBITOR; CHROMIUM; HEXAVALENT CHROMIUM; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CELL STRAIN; CELL STRAIN BEAS 2B; CELL STRAIN MOLT 4; DOSE RESPONSE; EPITHELIUM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHATIC LEUKEMIA; OCCUPATIONAL EXPOSURE; TIME; WESTERN BLOTTING;

APOPTOSIS; CARCINOGENS, ENVIRONMENTAL; CASPASES; CELL LINE; CELL LINE, TUMOR; CHROMIUM; DNA DAMAGE; HUMANS; LEUKEMIA, LYMPHOCYTIC; RESPIRATORY MUCOSA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33645554900     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000197859.46894.7d     Document Type: Article

References (48)

1. International Agency for Research on Cancer. Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, 49. Lyon: IARC; 1990:49-256.
2. De Flora S, Serra D, Camoirano A, Zanacchi P. Metabolic reduction of chromium, as related to its carcinogenic properties. Biol Trace Elem Res. 1989;21:179-187.
3. De Flora S, Camoirano A, Bagnasco M, Bennicelli C, Corbett GE, Kerger BD. Estimates of the chromium (VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis. 1997;18:531-537.
4. Shi X, Dalal NS. Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium (VI). Biochem Biophys Res Commun. 1989;163:627-634.
5. Shi X, Dalal NS. Evidence for a Fenton-type mechanism for the generation of hydroxyl radical in the reduction of Cr (VI) in cellular media. Arch Biochem Biophys. 1990;281:90-95.
6. Xu J, Wise JP, Patierno SR. DNA damage induced by carcinogenic lead chromate particles in cultured mammalian cells. Mutat Res. 1992;280:129-136.
7. Ye J, Zhang X, Young HA, Mao Y, Shi X. Chromium (VI)-induced nuclear factor-B activation in intact cells via free radical reactions. Carcinogenesis. 1995;16:2401-2405.
8. Shi X, Chiu A, Chen CT, Halliwell B, Castranova V, Vallyathan V. Reduction of chromium (VI) and its relationship to carcinogenesis. J Toxicol Environ Health B Crit Rev. 1999;2:87-104.
9. Stohs SJ, Bagchi D, Hassoun E, Bagchi M. Oxidative mechanism in the toxicity of chromium and cadmium ions. J Environ Pathol Toxicol Oncol. 2000;19:201-213.
10. Hodges NJ, Adam B, Lee AJ, Cross HJ, Chipman JK. Induction of DNA-strand breaks in human peripheral blood lymphocytes and A549 lung cells by sodium dichromate: association with 8-oxodeoxyguanosine formation and interindividual variability. Mutagenesis. 2001;16:467-474.
11. Ding M, Shi X. Molecular mechanism of Cr (VI)-induced carcinogenesis. Mol Cell Biochem. 2002;234:293-300.
12. Blankenship LJ, Manning FCR, Orenstein JM, et al. Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol Appl Pharmacol. 1994;126:75-83.
13. Shimada H, Shiao YH, Shibata MA, Waalkes MP. Cadmium suppresses apoptosis induced by chromium. J Toxicol Environ Health. 1998;54:159-169.
14. Flores A, Perez JM. Cytotoxicity, apoptosis and in vitro DNA damage induced by potassium chromate. Toxicol Appl Pharmacol. 1999;161:75-81.
15. D'Agostini F, Izzotti A, Bennicelli C, Camoirano A, Tampa E, De Flora S. Induction of apoptosis in the lung but not in the liver of rat receiving intra-tracheal instillation of chromium (VI). Carcinogenesis. 2002;23:587-593.
16. Waalkes MP, Fox DA, States JC, Patierno SR, McCabe MJ. Metals and disorders of cell accumulation: modulation of apoptosis and cell proliferation. Toxicol Sci. 2000;56:255-261.
17. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-306.
18. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 1984;142:67-77.
19. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312-1316.
20. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 1998;391:96-99.
21. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates and functions during apoptosis. Annu Rev Biochem. 1999;68:383-424.
22. Singh J, Carlisle DL, Pritchard DE, Patierno SR. Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis. Oncol Rep. 1998;5:1307-1318.
23. Pritchard DE, Ceryac S, Ha L, et al. Mechanism of apoptosis and determination of cellular fate in chromium (VI)-exposed populations of telomerase-immortalized fibroblasts. Cell Growth Diff. 2001;12:487-496.
24. Gottlieb TM, Oren M. p53 in growth control and neoplasia. Biochim Biophys Acta. 1996;1287:77-102.
25. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323-331.
26. Ullrich SJ, Anderson CW, Mercer WE, Appella E. The p53 tumor suppressor protein, a modulator of cell proliferation. J Biol Chem. 1992;267:15259-15262.
27. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J Biol Chem. 1998;273:1-4.
28. Carlisle DL, Pritchard DE, Singh J, Patierno SR. Chromium (VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol Carcinog. 2000;28:111-118a.
29. Carlisle DL, Pritchard DE, Singh J, et al. Apoptosis and p53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol. Toxicol Sci. 2000;55:60-68b.
30. Wang S, Leonard SS, Ye J, Ding M, Shi X. The role of hydroxyl radical as a messenger in Cr (VI)-induced p53 activation. Am J Physiol Cell Physiol. 2000;279:C868-C875.
31. Blankenship LJ, Crlisle DL, Wise JP, Orenstein JM, Dye LE, Patierno SR. Induction of apoptotic cell death by particular lead chromate: differential effects of vitamins C and E on genotoxicity and survival. Toxicol Appl Pharmacol. 1997;146:270-280.
32. Singh J, Pritchard DE, Carlisle DL, et al. Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicol Appl Pharmacol. 1999;161:240-248.
33. Bagchi D, Joshi SS, Bagchi M, et al. Cadmium- and chromium-induced oxidative stress, DNA damage, and apoptotic cell death in cultured human chronic myelogenous leukemic K562 cells, pro-myelocytic leukemic HL-60 cells, and normal human peripheral blood mononuclear cells. J Biochem Mol Toxicol. 2000;14:33-41.
34. Vasant C, Balamurugan K, Rajaram R, Ramasami T. Apoptosis of lymphocytes in the presence of Cr (VI) complexes: role in CR (VI)-induced toxicity. Biochem Biophys Res Commun. 2001;285:1354-1360.
35. Samet JM, Graves LM, Quay J, et al. Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am J Physiol. 1998;275:L551-L558.
36. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A simple and rapid method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271-279.
37. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature. 1994;3:372:100-103.
38. Manning FCR, Blankenship LJ, Wise JP, Xu J, Bridgewater LC, Patierno SR. Induction of internucleosomal DNA fragmentation by carcinogenic chromate: relationship to DNA damage, genotoxicity, and inhibition of macromolecular synthesis. Environ Health Perspect. 1994;102(suppl 3):159-167.
39. Yuan C, Kadiiska M, Achanzar WE, Mason RP, Waalkes MP. Possible role of caspase-3 inhibition in cadmium-induced blockage of apoptosis. Toxicol Appl Pharmacol. 2000;164:321-329.
40. Ye J, Wang S, Leonard SS, et al. Role of reactive oxygen species and p53 in chromium (VI)-induced apoptosis. J Biol Chem. 1999;274:34974-34980.
41. Wang S, Shi X. Mechanisms of Cr (VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK. Carcinogenesis. 2001;22:757-762.
42. Haynes RL, Brune B, Townsend AJ. Apoptosis in raw 264.7 cells exposed to 4-hydoxy-2-nonenal: dependence on cytochrome c release but not p53 accumulation. Free Radic Biol Med. 2001;30:884-894.
43. Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med. 1995;182:367-377.
44. Wallace KB, Eells JT, Madeira VM, Cortopassi G, Jones DP. Mitochondrial-mediated cell injury. Symposium overview. Fundam Appl Toxicol. 1997;38:23-37.
45. Chuang SM, Yang JL. Comparison of roles of three mitogen-activated protein kinases induced by chromium (VI) and cadmium in non-small-cell lung carcinoma cells. Mol Cell Biochem. 2001;222:85-95.
46. Izzotti A, Cartiglia C, Balansky R, D'Agostini F, Longobardi M, De Flora S. Selective induction of gene expression in rat lung by hexavalent chromium. Mol Carcinog. 2002;35:75-84.
47. Chen F, Shi X. Intracellular signal transduction of cells in response to carcinogenic metals. Crit Rev Oncol Hematol. 2002;42:105-121.
48. Charette SJ, Lambert H, Landry J. A kinase-independent function of ASK1 in caspase-independent cell death. J Biol Chem. 2001;276:36071-36074.